https://www.databridgemarketresearch.com/reports/global-castleman-disease-drug-market

Global Castleman Disease Drug Market growth at a CAGR of around 5.00% for the forecast period of the 2022-2028.

Castleman disease is a rare disease of lymphatic system wherein the immunity system of the body is adversely affected coupled with a significant impact on lymphs nodes, thymus, spleen, bone marrow and digestive tract. Also known as angiofollicular lymph node hyperplasia and giant lymph node hyperplasia, the castleman disease involves overgrowth of the lymph cells.